Groupe la Francaise Has $80.08 Million Stake in Intuitive Surgical, Inc. $ISRG

Groupe la Francaise grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 99.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 147,161 shares of the medical equipment provider’s stock after buying an additional 73,216 shares during the quarter. Intuitive Surgical accounts for about 1.3% of Groupe la Francaise’s portfolio, making the stock its 20th largest holding. Groupe la Francaise’s holdings in Intuitive Surgical were worth $80,081,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Aaron Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares in the last quarter. Exencial Wealth Advisors LLC boosted its stake in Intuitive Surgical by 3.1% in the first quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock valued at $327,000 after buying an additional 20 shares in the last quarter. Evergreen Capital Management LLC grew its position in Intuitive Surgical by 0.5% in the first quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after acquiring an additional 20 shares during the last quarter. Rise Advisors LLC raised its stake in Intuitive Surgical by 5.6% during the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after acquiring an additional 20 shares in the last quarter. Finally, Pinnacle Bancorp Inc. lifted its holdings in shares of Intuitive Surgical by 4.1% in the second quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after acquiring an additional 21 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $560.00, for a total value of $58,800.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the transaction, the executive vice president owned 5,758 shares in the company, valued at $3,310,850. The trade was a 37.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 86,804 shares of company stock valued at $48,043,866 in the last 90 days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 1.1%

ISRG opened at $567.37 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a fifty day moving average of $508.39 and a 200-day moving average of $504.67. The stock has a market cap of $203.39 billion, a PE ratio of 75.05, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the prior year, the firm posted $1.84 earnings per share. The business’s quarterly revenue was up 22.9% compared to the same quarter last year. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the subject of several research reports. Evercore ISI increased their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. UBS Group set a $600.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Daiwa Capital Markets boosted their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. The Goldman Sachs Group lifted their price target on Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Finally, Jefferies Financial Group upped their price objective on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $607.28.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.